About the Study : The authors of this Special Communication write that treatment of perinatal Major Depressive Disorder (MDD) should be prioritized during pregnancy. Authors argue that expanding access to maternity, child health, and psychiatric care is a public health imperative, and that structured, evidence-based decision-making can help clinicians and patients balance the risks of untreated depression, treatment benefits, and potential risks associated with SSRI exposure. Authors' institutions include Children's National Hospital, George Washington University School of Medicine, University of British Columbia, BC Children's Hospital Research Institute, Weill Cornell Medical College, Brigham and Women's Hospital, and Harvard Medical School.
Visit JAMA+ Women's Health for editor-curated JAMA Network research, commentary, and multimedia on this and related topics.
Corresponding Author : Katherine L. Wisner, MD, MS, Developing Brain Institute, Children’s National Hospital, 111 Michigan Ave NW, Washington, DC 20010 ( KWisner@childrensnational.org ).
10.1001/jamanetworkopen.2026.28578
To access the embargoed study: Visit our JAMA Network Media Center at this link https://media.jamanetwork.com/
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Editor's Note : Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
JAMA Network Open